Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin detemir added to liraglutide and metformin versus liraglutide and metformin in type 2 diabetes
2007-005317-19Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Oct 2008
- Modality
- Peptides, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in type 2 diabetes mellitus (T2DM) comparing Insulin detemir + liraglutide + metformin with Liraglutide + metformin (2 arms). Primary endpoint: Change in HbA1c from baseline to week 26. Started Oct 2008; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-005317-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005317-19.